Insulin Related Topics 
World of DTC Marketing
MARCH 31, 2022
The House is preparing to vote on a $35 monthly insulin cap later, but there is stern opposition to the plan, which could cost billions over ten years. Even with health insurance, some people pay up to $1,000 a month for insulin. Insulin Costs
World of DTC Marketing
DECEMBER 14, 2021
WHAT’S HAPPENING: In the Build Back Better bill , Democrats are actually proposing limiting insulin prices to $35 a month but Republicans can’t have any of that. PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 13, 2023
The state filed suit Thursday against pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, alleging they worked with drugmakers to drive up the price of insulin
Bio Pharma Dive
MARCH 3, 2022
The nonprofit group announced ambitious plans to begin offering insulin at prices no higher than $30 per vial by early 2024
Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin.
Bio Pharma Dive
JULY 11, 2022
Gavin Newsom announced a $100 million budget to create a production facility and to develop affordable insulin products, saying the medicines’ high cost “epitomizes market failures
Bio Pharma Dive
NOVEMBER 18, 2022
Eli Lilly’s long-acting copycat drug, first approved in late 2021, now has a designation that will allow pharmacists to swap it for Sanofi’s Lantus
Pharma Times
OCTOBER 11, 2022
Therapy demonstrates significantly accelerated insulin absorption and early exposure
Pharma Phorum
APRIL 29, 2022
For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27
Pharma Phorum
APRIL 13, 2022
The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing.
XTalks
NOVEMBER 15, 2022
In Lilly’s case, the fake account claimed the company was giving out free insulin. A fraudulent Eli Lilly account with the username @EliLillyandCo tweeted a message on November 10 that said: “We are excited to announce insulin is free now.”.
Pharma Phorum
NOVEMBER 11, 2022
In addition to the financial hit, the stunt has only served to draw attention to Lilly’s role in the insulin pricing crisis in the United States, where multiple patients have died because of rationing unaffordable insulin. That’s why other insulin stocks are falling too.
World of DTC Marketing
NOVEMBER 23, 2021
President Biden is set to address the cost of insulin but what about the costs of obesity which are in the billions? The post Insulin costs ignore the root cause of diabetes. OPENING: As the NY Times recently reported , obesity is the leading cause of mortality in the United States.
Pharmaceutical Technology
OCTOBER 12, 2022
Novo Nordisk has recently completed its six-part ONWARDS Phase III trial, as ONWARDS 5 reached its primary endpoint with Icodec demonstrating non-inferiority in reducing hemoglobin A1C (HbA1c) in patients with type 2 diabetes (T2D) at week 52 in comparison to once-daily basal insulin analogs.
Scienmag
JUNE 21, 2022
Diabetes is a lifelong, chronic health condition caused by abnormalities in the body’s production and use of the hormone insulin. Research has shown that the feel-good hormone, dopamine (DA), plays a key role in how the body regulates the production of insulin.
Pharma Phorum
JANUARY 25, 2023
It is also the first application to enable insulin delivery from a compatible Apple Watch. Image source: Tidepool.org The post Automated insulin dosing app Tidepool Loop FDA-cleared appeared first on.
Scienmag
MARCH 30, 2022
WASHINGTON—The Endocrine Society applauds the House of Representatives for hearing our call to improve insulin affordability for people with diabetes as it prepares to vote on the Affordable Insulin Now Act this week.
Pharmaceutical Technology
JANUARY 10, 2023
The SGLT-2I space is rapidly gaining market share from the DPP-4Is and other non-insulin anti-diabetic therapies as a barrage of clinical data in the last several years has demonstrated that they address the comorbidities of T2D.
Scienmag
JUNE 14, 2022
Latest News access among Diabetes disparities finds insulin pumps study type youth
Scienmag
MARCH 15, 2022
For millions of people with diabetes, insulin is essential medicine. But for some ocean-dwelling predators, insulin is a weapon. Chemistry AND Physics control Diabetes fastacting injectable inspires insulin Marine snail
Pharma Phorum
JANUARY 12, 2023
Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase 3 trial. The post Phase 3 trial dashes Oramed’s oral insulin hopes appeared first on.
Pharma Phorum
OCTOBER 4, 2022
Danish company Novo Nordisk have announced positive results from the ONWARDS 5 phase 3 trial, with once-weekly insulin icodec demonstrating superior reduction of HbA1 in people with type 2 diabetes, in combination with a dosing guide app.
BioPharma Reporter
MAY 5, 2022
Oramed Pharmaceuticals announced this week that it has enrolled 100% of the patients in the worldâs first Phase 3 study of oral insulin under FDA approved protocols.
Scienmag
JANUARY 4, 2022
LA JOLLA—(January 4, 2022) The discovery of insulin 100 years ago opened a door that would lead to life and hope for millions of people with diabetes. Biology blood find independent insulin levels regulating researchers route Salk sugar
BioSpace
JUNE 2, 2022
The results showed that insulin icodec is as non-inferior to Sanofi’s insulin glargine, Lantus, potentially bringing another major competitor into the insulin space
BioPharma Reporter
NOVEMBER 21, 2022
Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.
XTalks
OCTOBER 8, 2021
Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks.
Pharma Times
APRIL 29, 2022
InRange is the first worldwide multicentre RCT to compare second generation basal insulins
Fierce Pharma
NOVEMBER 18, 2022
Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim. fkansteiner. Fri, 11/18/2022 - 11:01
Scienmag
APRIL 13, 2022
ET, WEDNESDAY, APRIL 13, 2022 Exercise May Protect Brain Volume by Keeping Insulin and BMI Levels Low MINNEAPOLIS – Studies have shown that exercise helps protect brain cells. A new study looking at the mechanisms involved in this relationship suggests that the role exercise plays in maintaining insulin and […]. Latest News BMI brain Exercise insulin Keeping levels protect VolumeEMBARGOED FOR RELEASE UNTIL 4 P.M.
NY Times
MARCH 31, 2022
Diabetes Law and Legislation Drugs (Pharmaceuticals) Insulin Prices (Fares, Fees and Rates) United States Politics and Government Democratic Party House of Representatives Senate Biden, Joseph R Jr
Scienmag
JULY 21, 2022
Latest News Cystic Diabetes fibrosis hormone improves infusion insulin pancreatic Patients production riskCystic fibrosis is well-known for attacking the lungs through thick blockages of mucus, but those with the condition often also develop diabetes because of the way cystic fibrosis can affect the pancreas. Since diabetes has been linked to worse lung function, this creates a vicious cycle, with diabetes acting as a multiplier on the patient’s […].
Scienmag
JANUARY 19, 2022
Biology Black Diabetes differences factor gut insulin microbiome resistance risk white women
Pharma Phorum
MARCH 2, 2022
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8
Pharma Phorum
MAY 13, 2022
Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers – Eli Lilly, Sanofi and Novo Nordisk – accusing them of deceptively driving up the price of the medicines. Today we begin the fight to stop this outrageous inflation of insulin pricing.”
Bio Pharma Dive
JULY 14, 2021
Rival Novo Nordisk has jumped ahead in developing an injectable drug that responds to changes in blood sugar. An acquisition of Protomer Therapeutics could help Lilly close the gap
Pharma Phorum
JULY 14, 2021
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. .
Pharma Phorum
MARCH 23, 2022
The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the monthly cost of insulin to patients that was endorsed by President Joe Biden in his 2022 State of the Union address. Some companies are already taking steps to provide lower-cost insulin.
Fierce Pharma
JUNE 29, 2022
With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US. kdunleavy. Wed, 06/29/2022 - 11:28
Scienmag
SEPTEMBER 29, 2021
Pancreatic beta cells produce, store and secrete insulin upon elevated blood glucose levels. However, the highly regulated process of insulin secretion, especially its molecular features and the stimuli behind this process have not yet been fully understood.
BioSpace
JUNE 9, 2022
million Americans who have diabetes, insulin has become increasingly expensive. Here are four organizations dedicated to making insulin more accessible For the 37.3
The Pharma Data
APRIL 28, 2022
Novo Nordisk today announced headline results from the ONWARDS 2 trial, a phase 3a, 26-week efficacy and safety treat-to-target trial investigating once-weekly insulin icodec vs insulin degludec in 526 people with type 2 diabetes switching from daily insulin.
Expert insights. Personalized for you.
203 
Let's personalize your content